Keyan Matinpour, MD

Keyan Matinpour, MD, is a Board Certified Dermatologist and fellowship-trained in Mohs Micrographic Surgery and Dermatologic Oncology. Dr. Matinpour received his medical degree from UCLA David Geffen School of Medicine and was inducted into the Alpha Omega Alpha Honor Medical Society after graduating at the top of his class. During his training at UCLA, he was also awarded with the prestigious Longmire Medal Award from the Department of Surgery, which selects only one student from each graduating class. After completing his intern year at Cedars-Sinai Medical Center in internal medicine, Dr. Matinpour began his dermatology residency training at Baylor College of Medicine, located in the Texas Medical Center - the world's largest medical center and well-known for its cancer care. After graduating from his residency program, he pursued further training with an American College of Mohs Surgery (ACMS) approved fellowship in Mohs Micrographic Surgery and Dermatologic Oncology at Houston Methodist Hospital, with the world-renowned Leonard H. Goldberg, MD. 

Dr. Matinpour knew from a young age he wanted to pursue a career in medicine. At UCLA, he enjoyed all aspects of his education, but had a strong desire to pursue a surgical field. He decided to focus on dermatology and micrographic surgery, stating: 

"In dermatology, I'm able to treat everyone of all ages and genders - with different types of diseases - infectious, oncologic, genetic and auto-immune, among others. I'm particularly passionate about preventing and treating skin cancer. Mohs micrographic surgery enables me to provide patients with the highest cure rate possible, while sparing their healthy tissue."

Dr. Matinpour is married to Patricia Cummings, MPH, PhD, an epidemiologist at Eisenhower Health. He is an animal lover with two dogs. In his spare time, he enjoys music, art and plays the guitar.

What is Mohs surgery:

Mohs micrographic surgery is a specialized, highly effective technique for the removal of skin cancer. The procedure was developed in the 1930s by Frederic Mohs, MD, at the University of Wisconsin and is now practiced throughout the world. Mohs surgery differs from other skin cancer treatments in that it permits the immediate and complete microscopic examination of the removed cancerous tissue, so that all "roots" and extensions of the cancer can be eliminated. Due to the methodical manner in which tissue is removed and examined, Mohs surgery has been recognized as the skin cancer treatment with the highest reported cure rate. (American Society for Mohs Surgery)